Ayala Pharmaceuticals Inc (ADXS)

[CATTDOGG12347]

So, PPS wise Aduro is worth a dollar more per share. Their products are toxic in higher doses, have to be given in combination with multiple other drugs to get a product that might have a chance of approval, Yvonne Paterson threw the tech they are using in the trash can where it was picked up by Aduro's founder and their potential products can't be sold in Europe due to patent infringement.
They recently had a failed trial as well but yet their market cap is double that of ours. I hope you all can make sense of this.